- Home
- PRE vs ATNM Comparison
PRE vs ATNM Comparison
Compare PRE & ATNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRE
- ATNM
- Stock Information
- Founded
- PRE 2014
- ATNM 2000
- Country
- PRE Hong Kong
- ATNM United States
- Employees
- PRE N/A
- ATNM N/A
- Industry
- PRE Biotechnology: Laboratory Analytical Instruments
- ATNM Biotechnology: Pharmaceutical Preparations
- Sector
- PRE Industrials
- ATNM Health Care
- Exchange
- PRE Nasdaq
- ATNM Nasdaq
- Market Cap
- PRE 60.2M
- ATNM 56.5M
- IPO Year
- PRE N/A
- ATNM N/A
- Fundamental
- Price
- PRE $4.50
- ATNM $1.51
- Analyst Decision
- PRE Buy
- ATNM Strong Buy
- Analyst Count
- PRE 1
- ATNM 5
- Target Price
- PRE $9.00
- ATNM $14.20
- AVG Volume (30 Days)
- PRE 5.3K
- ATNM 245.6K
- Earning Date
- PRE 11-26-2024
- ATNM 11-26-2024
- Dividend Yield
- PRE N/A
- ATNM N/A
- EPS Growth
- PRE N/A
- ATNM N/A
- EPS
- PRE N/A
- ATNM N/A
- Revenue
- PRE $22,662,330.00
- ATNM $81,000.00
- Revenue This Year
- PRE $64.44
- ATNM $186.10
- Revenue Next Year
- PRE $154.24
- ATNM $19,248.94
- P/E Ratio
- PRE N/A
- ATNM N/A
- Revenue Growth
- PRE N/A
- ATNM 80.00
- 52 Week Low
- PRE $2.85
- ATNM $1.33
- 52 Week High
- PRE $7.84
- ATNM $10.24
- Technical
- Relative Strength Index (RSI)
- PRE 48.01
- ATNM 36.23
- Support Level
- PRE $4.43
- ATNM $1.82
- Resistance Level
- PRE $4.88
- ATNM $1.97
- Average True Range (ATR)
- PRE 0.23
- ATNM 0.12
- MACD
- PRE 0.01
- ATNM -0.02
- Stochastic Oscillator
- PRE 55.14
- ATNM 11.52
About PRE Prenetics Global Limited
Prenetics Global Ltd is a health sciences company, that is dedicated to consumer and clinical health. Its consumer initiative is led by IM8, a new health and wellness brand. The clinical division is led by Insighta, focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer DNA tests. Each Prenetics unit impacts health by 'enhancing life through science'.
About ATNM Actinium Pharmaceuticals Inc. (Delaware)
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.